Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Immunodeficiencies and Immunologic Diseases Panel (Complete) Mendelics Brazil | 1 | 397 |
|
Primary Ciliary Dyskinesia Panel Mendelics Brazil | 1 | 35 |
|
GLOBAL CILIOPATHIES EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 273 |
|
HETEROTAXY & SITUS INVERSUS EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 41 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Ciliary dyskinesia and heterotaxia. NGS panel of 40 genes. Genologica Medica Spain | 49 | 40 |
|
Primary ciliary dyskinesia panel. 36-gene NGS panel. Genologica Medica Spain | 46 | 35 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
CCNO Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Prenatal Known Familial Mutation GeneDx United States | 1 | 1716 |
|
Primary Ciliary Dyskinesia (PCD) Mutation Testing Molecular Genetics University of North Carolina Hospitals United States | 1 | 38 |
|
Custom XomeDxSlice (2-150 Genes, Proband Only) GeneDx United States | 1 | 1718 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 64 | 66 |
|
Primary Ciliary Dyskinesia panel Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 36 | 38 |
|
NewbornDx Advanced Sequencing Evaluation Athena Diagnostics United States | 1 | 1722 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Primary Ciliary Dyskinesia NGS Panel Fulgent Genetics United States | 55 | 38 |
|
Congenital Heart Defect NGS Panel Fulgent Genetics United States | 377 | 114 |
|
Asper Biogene Asper Biogene LLC Estonia | 33 | 35 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.